Your browser doesn't support javascript.
loading
Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.
Fahrmann, Johannes F; Wasylishen, Amanda R; Pieterman, Carolina R C; Irajizad, Ehsan; Vykoukal, Jody; Wu, Ranran; Dennison, Jennifer B; Peterson, Christine B; Zhao, Hua; Do, Kim-Anh; Halperin, Daniel M; Agarwal, Sunita K; Blau, Jenny E; Jha, Smita; Rivero, Jaydira Del; Nilubol, Naris; Walter, Mary F; Welch, James M; Weinstein, Lee S; Vriens, Menno R; van Leeuwaarde, Rachel S; van Treijen, Mark J C; Valk, Gerlof D; Perrier, Nancy D; Hanash, Samir M; Katayama, Hiroyuki.
Affiliation
  • Fahrmann JF; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Wasylishen AR; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Pieterman CRC; Department of Cancer Biology, University of Cincinnati, Cincinnati, OH 45267, USA.
  • Irajizad E; Department of Surgical Oncology, Section of Surgical Endocrinology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Vykoukal J; Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht 3508 GA, the Netherlands.
  • Wu R; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Dennison JB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Peterson CB; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Zhao H; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Do KA; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Halperin DM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Agarwal SK; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Blau JE; Department of Family Medicine and Population Health, Virginia Commonwealth University, Richmond, VA 23284, USA.
  • Jha S; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Rivero JD; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Nilubol N; Metabolic Diseases Branch, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Walter MF; Metabolic Diseases Branch, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Welch JM; Metabolic Diseases Branch, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Weinstein LS; Developmental Therapeutics Branch, The National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Vriens MR; Surgical Oncology Program, The National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • van Leeuwaarde RS; Core for Clinical Laboratory Services, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • van Treijen MJC; Metabolic Diseases Branch, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Valk GD; Metabolic Diseases Branch, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Perrier ND; Department of Surgical Oncology and Endocrine Surgery, University Medical Center Utrecht, Utrecht 3584 CX, the Netherlands.
  • Hanash SM; Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute Amsterdam, University Medical Center Utrecht, Utrect 1066 CX, the Netherlands.
  • Katayama H; Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute Amsterdam, University Medical Center Utrecht, Utrect 1066 CX, the Netherlands.
J Clin Endocrinol Metab ; 108(12): 3260-3271, 2023 Nov 17.
Article in En | MEDLINE | ID: mdl-37307230
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Neuroendocrine Tumors / Multiple Endocrine Neoplasia Type 1 Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: J Clin Endocrinol Metab Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Neuroendocrine Tumors / Multiple Endocrine Neoplasia Type 1 Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: J Clin Endocrinol Metab Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States